Concepedia

Hao Li

HL

11

Publications

446

Citations

10

H-Index

2011

Active since

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Wuhan University

Sun Yat-sen University

The University of Texas Southwestern Medical Center

Hao Li is an author at First Affiliated Hospital of Zhengzhou University specializing in tumor biology, cancer research, and oncology.

ORCID

Top concepts

Publications per year

2011–2024

11

Publications

11

Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice

Hongwei Wang, Madhukumar Venkatesh, Hao Li et al. · Journal of Clinical Investigation · 2011 · 140 citations · Full text

, , +14

Circular RNA circ‐Foxo3 inhibits esophageal squamous cell cancer progression via the miR‐23a/PTEN axis

Xing Yao, Wenjuan Zha, Xiaomin Li et al. · Journal of Cellular Biochemistry · 2019 · 96 citations

, , +16

FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma

Yue Chen, Tian Tian, Zhiyong Li et al. · Cell Death and Disease · 2019 · 44 citations · Full text

<p>Upregulated <em>circPDK1</em> Promotes RCC Cell Migration and Invasion by Regulating the <em>miR-377-3P-NOTCH1</em> Axis in Renal Cell Carcinoma</p>

Zhenlin Huang, Yinghui Ding, Lu Zhang et al. · OncoTargets and Therapy · 2020 · 37 citations · Full text

SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors

Zhenlin Huang, Xiang Li, Bo Tang et al. · Cancer Research · 2023 · 28 citations

Rows per page

1–5 of 11